DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN

DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN was reported 20558 times

DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ARTERIOGRAM CAROTID ABNORMAL 1 0.1111
1 OROPHARYNGEAL SURGERY 1 0.0222
2 HALLUCINATION, SYNAESTHETIC 1 0.0172
3 MONONUCLEAR CELL COUNT ABNORMAL 1 0.0137
4 INFUSION SITE HYPOAESTHESIA 1 0.0105
5 RUBELLA 1 0.0088
6 CARDIAC MONITORING 1 0.0082
7 ENDOMETRIAL CANCER STAGE I 1 0.0060
8 INTERNAL HERNIA 1 0.0060
9 INFUSION SITE INJURY 1 0.0057
10 ADMINISTRATION SITE DISCOMFORT 1 0.0053
11 GLOBAL AMNESIA 1 0.0047
12 PRODUCT ADVERTISING ISSUE 1 0.0047
13 COLD URTICARIA 1 0.0045
14 SPLINTER 1 0.0043
15 LOCKED-IN SYNDROME 2 0.0043
16 GENITAL DISCHARGE 1 0.0042
17 MOLE EXCISION 1 0.0041
18 SPONTANEOUS BACTERIAL PERITONITIS 1 0.0041
19 MICROCYTOSIS 1 0.0040
20 BENIGN LUNG NEOPLASM 1 0.0040
21 ERYTHEMA INFECTIOSUM 1 0.0039
22 LOWER RESPIRATORY TRACT INFLAMMATION 1 0.0037
23 EAR INFECTION BACTERIAL 1 0.0037
24 OESOPHAGEAL OEDEMA 1 0.0035
25 RENAL HYPERTENSION 1 0.0032
26 MUMPS 1 0.0032
27 SCARLET FEVER 1 0.0031
28 EYE INFECTION VIRAL 1 0.0031
29 ADMINISTRATION SITE SWELLING 1 0.0031
30 INFUSION SITE MASS 3 0.0028
31 SYSTEMIC SCLERODERMA 2 0.0027
32 FEEDING TUBE USER 1 0.0027
33 ACETABULUM FRACTURE 1 0.0027
34 IMPLANT SITE DISCHARGE 1 0.0027
35 SENSATION OF BLOOD FLOW 1 0.0026
36 LOWER RESPIRATORY TRACT INFECTION FUNGAL 1 0.0026
37 BRONCHITIS ACUTE 1 0.0025
38 OBSTRUCTIVE UROPATHY 1 0.0025
39 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 1 0.0024
40 INFUSION SITE SCAR 1 0.0023
41 HAEMORRHOID OPERATION 1 0.0022
42 ALLERGY TO PLANTS 1 0.0022
43 ALLERGY TO ARTHROPOD STING 1 0.0022
44 INFUSION SITE INFECTION 5 0.0021
45 DYSPHASIA 1 0.0021
46 INJURY CORNEAL 1 0.0019
47 HYPERMETABOLISM 1 0.0019
48 FRACTURE PAIN 1 0.0019
49 INTERTRIGO 1 0.0018
50 HYPERTENSIVE URGENCY 1 0.0018
51 TENOSYNOVITIS STENOSANS 1 0.0018
52 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 1 0.0018
53 LIGAMENT INJURY 2 0.0018
54 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 1 0.0017
55 HYPOAESTHESIA EYE 1 0.0017
56 DERMATILLOMANIA 1 0.0017
57 ENDOSCOPY 1 0.0017
58 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
59 BLOOD VISCOSITY INCREASED 1 0.0017
60 POST-ACUTE COVID-19 SYNDROME 2 0.0016
61 HYPERCHLORAEMIA 1 0.0016
62 MUCOSAL DISCOLOURATION 1 0.0016
63 FOREIGN BODY IN RESPIRATORY TRACT 2 0.0015
64 LIP EXFOLIATION 2 0.0015
65 BRONCHITIS VIRAL 1 0.0015
66 STASIS DERMATITIS 1 0.0015
67 INFUSION SITE RASH 2 0.0015
68 CONTRAINDICATED DRUG ADMINISTERED 1 0.0014
69 H1N1 INFLUENZA 2 0.0014
70 DERMATITIS DIAPER 1 0.0014
71 NASAL INJURY 1 0.0014
72 GENITAL PAIN 2 0.0014
73 SERRATIA INFECTION 1 0.0013
74 CATHETER SITE RELATED REACTION 1 0.0013
75 ALLERGIC COUGH 1 0.0013
76 INFECTION PARASITIC 1 0.0013
77 TRANSCRIPTION MEDICATION ERROR 2 0.0013
78 ENDOCARDITIS BACTERIAL 1 0.0013
79 ELECTROMECHANICAL DISSOCIATION 1 0.0013
80 SINUSITIS FUNGAL 1 0.0012
81 INTERVERTEBRAL DISC SPACE NARROWING 1 0.0012
82 BRONCHITIS CHRONIC 3 0.0012
83 CHEMICAL INJURY 1 0.0012
84 CSF PROTEIN INCREASED 1 0.0012
85 ADRENAL MASS 1 0.0012
86 INCISION SITE COMPLICATION 1 0.0012
87 INFUSION SITE OEDEMA 1 0.0012
88 CRANIOFACIAL FRACTURE 1 0.0012
89 GINGIVAL ERYTHEMA 1 0.0012
90 OESOPHAGEAL OBSTRUCTION 1 0.0012
91 INFUSION SITE DISCOLOURATION 1 0.0011
92 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
93 ESSENTIAL HYPERTENSION 2 0.0011
94 PHARYNGEAL HYPOAESTHESIA 1 0.0011
95 CATHETER SITE SWELLING 1 0.0011
96 CHRONIC SINUSITIS 4 0.0011
97 BRAIN STEM HAEMORRHAGE 1 0.0011
98 INFUSION SITE NODULE 1 0.0010
99 DEVICE RELATED THROMBOSIS 1 0.0010
100 RECTAL POLYP 1 0.0010
101 SPUTUM RETENTION 1 0.0010
102 AXILLARY MASS 1 0.0010
103 DEVICE CONNECTION ISSUE 2 0.0009
104 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
105 HYPERTENSIVE NEPHROPATHY 1 0.0009
106 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
107 INFUSION SITE BRUISING 2 0.0009
108 NEPHROSCLEROSIS 1 0.0009
109 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
110 ARTERIAL HAEMORRHAGE 1 0.0009
111 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
112 PUPILS UNEQUAL 1 0.0009
113 ADMINISTRATION SITE PAIN 1 0.0009
114 NEPHROGENIC ANAEMIA 4 0.0009
115 MUCOSAL HAEMORRHAGE 1 0.0009
116 INTRUSIVE THOUGHTS 1 0.0008
117 REFLUX GASTRITIS 1 0.0008
118 CHRONIC RESPIRATORY FAILURE 1 0.0008
119 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
120 DEVICE INFUSION ISSUE 2 0.0008
121 SEROMA 1 0.0008
122 BRONCHIAL SECRETION RETENTION 1 0.0008
123 INCREASED BRONCHIAL SECRETION 2 0.0008
124 CLUSTER HEADACHE 1 0.0007
125 INTESTINAL MASS 1 0.0007
126 PROTHROMBIN TIME SHORTENED 1 0.0007
127 DRUG TOLERANCE DECREASED 2 0.0007
128 BLOOD ELECTROLYTES DECREASED 1 0.0007
129 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
130 SEBORRHOEIC KERATOSIS 1 0.0007
131 JUDGEMENT IMPAIRED 1 0.0007
132 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
133 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
134 PULMONARY PAIN 2 0.0007
135 DARK CIRCLES UNDER EYES 1 0.0007
136 PRECANCEROUS SKIN LESION 1 0.0007
137 CHOLANGIOCARCINOMA 1 0.0007
138 HYPOSMIA 1 0.0007
139 REBOUND ACID HYPERSECRETION 2 0.0007
140 EYE ALLERGY 1 0.0006
141 SUBSTANCE USE 1 0.0006
142 SINUS ARREST 1 0.0006
143 MULTIPLE ALLERGIES 5 0.0006
144 MEDICAL DEVICE IMPLANTATION 1 0.0006
145 INAPPROPRIATE AFFECT 1 0.0006
146 ANALGESIC DRUG LEVEL INCREASED 1 0.0006
147 OVARIAN CANCER RECURRENT 1 0.0006
148 CYSTITIS INTERSTITIAL 1 0.0006
149 COLON CANCER METASTATIC 1 0.0006
150 STRONGYLOIDIASIS 1 0.0006
151 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
152 SHOULDER FRACTURE 1 0.0006
153 INFUSION SITE HAEMORRHAGE 2 0.0006
154 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
155 MITRAL VALVE PROLAPSE 1 0.0006
156 SPLEEN DISORDER 1 0.0006
157 SEIZURE LIKE PHENOMENA 1 0.0006
158 LAZINESS 1 0.0006
159 INCREASED UPPER AIRWAY SECRETION 3 0.0006
160 MILIARIA 1 0.0006
161 FIXED ERUPTION 1 0.0006
162 TRISMUS 3 0.0006
163 DROOLING 4 0.0006
164 MEDICAL DEVICE REMOVAL 1 0.0006
165 HYPOPNOEA 2 0.0006
166 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
167 SPINAL CORD INJURY 1 0.0006
168 INFUSION SITE DISCHARGE 1 0.0006
169 FANCONI SYNDROME ACQUIRED 1 0.0006
170 HEREDITARY ANGIOEDEMA 6 0.0006
171 INJECTION SITE DISCHARGE 3 0.0006
172 PRODUCT TAMPERING 1 0.0006
173 BONE LESION 2 0.0006
174 OESOPHAGEAL SPASM 1 0.0005
175 LIP DISORDER 1 0.0005
176 HYPERCOAGULATION 1 0.0005
177 ARTERIAL DISORDER 1 0.0005
178 HEPATIC MASS 1 0.0005
179 ARTERIAL THROMBOSIS 1 0.0005
180 GALLBLADDER INJURY 1 0.0005
181 HYPOGEUSIA 1 0.0005
182 FOREIGN BODY 2 0.0005
183 FUNGAL SKIN INFECTION 2 0.0005
184 SEASONAL ALLERGY 7 0.0005
185 EAR HAEMORRHAGE 1 0.0005
186 OSTEOLYSIS 1 0.0005
187 IMPAIRED SELF-CARE 1 0.0005
188 SLEEP TERROR 2 0.0005
189 SENSATION OF FOREIGN BODY 4 0.0005
190 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
191 SLEEP DEFICIT 1 0.0005
192 RENAL NEOPLASM 1 0.0005
193 CATHETER SITE ERYTHEMA 1 0.0005
194 PROCTALGIA 3 0.0005
195 CARDIAC FLUTTER 3 0.0005
196 REACTION TO DRUG EXCIPIENTS 1 0.0005
197 DIVERTICULUM INTESTINAL 2 0.0005
198 RHINITIS ALLERGIC 2 0.0004
199 CALCINOSIS 1 0.0004
200 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0004
201 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
202 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
203 LIP DRY 4 0.0004
204 HAEMOGLOBIN INCREASED 2 0.0004
205 BREAKTHROUGH PAIN 1 0.0004
206 NECK SURGERY 1 0.0004
207 MENOPAUSAL SYMPTOMS 1 0.0004
208 ORAL SURGERY 1 0.0004
209 PUSTULE 1 0.0004
210 SINUS OPERATION 1 0.0004
211 INCORRECT DOSAGE ADMINISTERED 2 0.0004
212 HAEMATOLOGICAL INFECTION 1 0.0004
213 RETINAL TEAR 1 0.0004
214 HEART INJURY 1 0.0004
215 GASTROINTESTINAL TUBE INSERTION 1 0.0004
216 HYPERPARATHYROIDISM SECONDARY 1 0.0004
217 CHROMATURIA 9 0.0004
218 OSTEITIS 1 0.0004
219 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
220 CATHETER SITE PAIN 1 0.0004
221 ACTINIC KERATOSIS 1 0.0004
222 FAILURE TO THRIVE 2 0.0004
223 COMPARTMENT SYNDROME 1 0.0004
224 PRODUCT CLEANING INADEQUATE 1 0.0004
225 ANAESTHETIC COMPLICATION 1 0.0004
226 PRODUCT SIZE ISSUE 2 0.0004
227 LIP BLISTER 1 0.0004
228 CLONUS 1 0.0004
229 MACULE 1 0.0004
230 CHOKING 7 0.0004
231 OXYGEN SATURATION ABNORMAL 1 0.0004
232 MICTURITION URGENCY 4 0.0003
233 EXERCISE TOLERANCE DECREASED 2 0.0003
234 PARAPLEGIA 1 0.0003
235 HYPERTONIC BLADDER 1 0.0003
236 GASTROINTESTINAL NECROSIS 1 0.0003
237 DEVICE POWER SOURCE ISSUE 1 0.0003
238 NECK INJURY 1 0.0003
239 STRABISMUS 1 0.0003
240 ENERGY INCREASED 2 0.0003
241 BRADYKINESIA 2 0.0003
242 PRODUCTIVE COUGH 16 0.0003
243 EMERGENCY CARE 1 0.0003
244 EYE INJURY 1 0.0003
245 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
246 RETINAL DETACHMENT 3 0.0003
247 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
248 BLOOD CREATININE DECREASED 1 0.0003
249 PRODUCT USE COMPLAINT 5 0.0003
250 INFUSION SITE PRURITUS 1 0.0003
251 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
252 BLADDER PAIN 1 0.0003
253 INFUSION SITE PAIN 4 0.0003
254 SKIN EROSION 1 0.0003
255 INCOHERENT 2 0.0003
256 FACET JOINT SYNDROME 1 0.0003
257 PHARYNGEAL SWELLING 3 0.0003
258 LYMPHOCYTE COUNT INCREASED 1 0.0003
259 POLYP 2 0.0003
260 SOMNAMBULISM 2 0.0003
261 DYSGRAPHIA 2 0.0003
262 SUSPECTED COVID-19 1 0.0003
263 NEAR DEATH EXPERIENCE 1 0.0003
264 SKIN INJURY 1 0.0003
265 PEPTIC ULCER 1 0.0003
266 THERAPEUTIC AGENT TOXICITY 1 0.0003
267 SKIN MASS 2 0.0003
268 CHOLECYSTITIS CHRONIC 2 0.0003
269 METASTASES TO SPINE 1 0.0003
270 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
271 THROAT TIGHTNESS 8 0.0003
272 DIABETIC RETINOPATHY 1 0.0003
273 B-CELL LYMPHOMA 1 0.0003
274 BLOOD TESTOSTERONE DECREASED 2 0.0003
275 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
276 LEFT VENTRICULAR FAILURE 1 0.0003
277 RESPIRATION ABNORMAL 2 0.0003
278 MICTURITION DISORDER 1 0.0003
279 EAR PRURITUS 1 0.0003
280 INCONTINENCE 3 0.0003
281 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
282 PANIC REACTION 2 0.0003
283 SKIN LACERATION 3 0.0003
284 FREEZING PHENOMENON 1 0.0003
285 ARTHROPOD BITE 2 0.0003
286 FEELING DRUNK 2 0.0003
287 RESPIRATORY TRACT INFECTION 7 0.0003
288 SKIN INFECTION 3 0.0003
289 EYE INFECTION 3 0.0003
290 HEPATIC NECROSIS 1 0.0003
291 SNORING 1 0.0003
292 ECONOMIC PROBLEM 4 0.0003
293 FACE INJURY 1 0.0003
294 INTERNAL HAEMORRHAGE 3 0.0003
295 GASTRIC INFECTION 1 0.0003
296 CLAVICLE FRACTURE 1 0.0003
297 RENAL FAILURE CHRONIC 2 0.0003
298 OESOPHAGEAL DISORDER 1 0.0003
299 SENSATION OF HEAVINESS 1 0.0003
300 RHINOVIRUS INFECTION 1 0.0003
301 DYSPHONIA 15 0.0003
302 ORAL HERPES 5 0.0003
303 ORAL INFECTION 1 0.0003
304 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
305 PROSTATOMEGALY 1 0.0003
306 SKIN ODOUR ABNORMAL 1 0.0003
307 OESOPHAGEAL PAIN 1 0.0003
308 RESPIRATORY TRACT CONGESTION 4 0.0003
309 HAEMOPTYSIS 7 0.0003
310 OESOPHAGEAL CANDIDIASIS 1 0.0003
311 OBSTRUCTION 1 0.0003
312 ENURESIS 1 0.0002
313 COUGH 69 0.0002
314 PERIPHERAL ISCHAEMIA 1 0.0002
315 PERIPHERAL VENOUS DISEASE 1 0.0002
316 POLYURIA 2 0.0002
317 GOITRE 1 0.0002
318 DEMYELINATION 1 0.0002
319 MUSCLE INJURY 2 0.0002
320 EPISTAXIS 18 0.0002
321 AGEUSIA 6 0.0002
322 HALLUCINATIONS, MIXED 1 0.0002
323 INFUSION SITE ERYTHEMA 2 0.0002
324 HALLUCINATION, VISUAL 5 0.0002
325 THROAT CANCER 1 0.0002
326 URINARY INCONTINENCE 7 0.0002
327 CARDIAC FAILURE CHRONIC 1 0.0002
328 MUSCLE STRAIN 2 0.0002
329 HORDEOLUM 1 0.0002
330 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
331 BRONCHITIS 17 0.0002
332 IMMOBILE 1 0.0002
333 URINE OUTPUT DECREASED 2 0.0002
334 BLOOD CREATINE INCREASED 1 0.0002
335 OROPHARYNGEAL DISCOMFORT 2 0.0002
336 GINGIVAL BLEEDING 3 0.0002
337 END STAGE RENAL DISEASE 4 0.0002
338 ABDOMINAL HERNIA 1 0.0002
339 WHEEZING 13 0.0002
340 EAR DISORDER 1 0.0002
341 PNEUMONIA BACTERIAL 2 0.0002
342 ABNORMAL DREAMS 6 0.0002
343 NERVE COMPRESSION 2 0.0002
344 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
345 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
346 RENAL FUNCTION TEST ABNORMAL 1 0.0002
347 ROSACEA 1 0.0002
348 SKIN ABRASION 1 0.0002
349 BRONCHOSPASM 3 0.0002
350 DISEASE RECURRENCE 10 0.0002
351 GESTATIONAL DIABETES 1 0.0002
352 LIMB OPERATION 1 0.0002
353 HUMERUS FRACTURE 1 0.0002
354 HERNIA 4 0.0002
355 PARKINSONISM 2 0.0002
356 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
357 COELIAC DISEASE 2 0.0002
358 HYPERVOLAEMIA 1 0.0002
359 EXPIRED DRUG ADMINISTERED 1 0.0002
360 ANEURYSM 1 0.0002
361 THROAT IRRITATION 9 0.0002
362 HEPATIC ENZYME ABNORMAL 1 0.0002
363 FLUID INTAKE REDUCED 1 0.0002
364 CORONARY ARTERY STENOSIS 1 0.0002
365 OSTEOPENIA 3 0.0002
366 PATHOLOGICAL FRACTURE 1 0.0002
367 DYSLIPIDAEMIA 1 0.0002
368 AMMONIA INCREASED 1 0.0002
369 CEREBRAL ISCHAEMIA 1 0.0002
370 TEMPERATURE INTOLERANCE 2 0.0002
371 DELUSION 3 0.0002
372 HYPERBILIRUBINAEMIA 2 0.0002
373 VENTRICULAR EXTRASYSTOLES 2 0.0002
374 BRAIN FOG 3 0.0002
375 RESTLESSNESS 7 0.0002
376 CATATONIA 1 0.0002
377 RENAL PAIN 2 0.0002
378 NYSTAGMUS 1 0.0002
379 ANORECTAL DISCOMFORT 1 0.0002
380 RETCHING 4 0.0002
381 JOINT INJURY 4 0.0002
382 DYSPNOEA EXERTIONAL 7 0.0002
383 GINGIVITIS 1 0.0002
384 BEHAVIOUR DISORDER 1 0.0002
385 BACK DISORDER 3 0.0002
386 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
387 ASPIRATION 2 0.0002
388 CHOKING SENSATION 1 0.0002
389 URINARY RETENTION 6 0.0002
390 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
391 EYE PRURITUS 6 0.0002
392 MITRAL VALVE INCOMPETENCE 2 0.0002
393 SINUSITIS 18 0.0002
394 NEUROLOGICAL SYMPTOM 1 0.0002
395 PARANOIA 3 0.0002
396 METABOLIC DISORDER 1 0.0002
397 LOCAL SWELLING 3 0.0002
398 SKIN WARM 1 0.0002
399 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
400 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
401 HYPOXIA 6 0.0002
402 SINUS HEADACHE 1 0.0002
403 NASOPHARYNGITIS 31 0.0002
404 GALLBLADDER DISORDER 3 0.0002
405 THIRST 3 0.0002
406 PROTHROMBIN TIME PROLONGED 1 0.0002
407 WRIST FRACTURE 2 0.0002
408 BLOOD POTASSIUM DECREASED 5 0.0002
409 INJECTION SITE VESICLES 1 0.0002
410 BURSITIS 2 0.0002
411 INGUINAL HERNIA 1 0.0002
412 MENISCUS INJURY 1 0.0002
413 SMALL INTESTINAL OBSTRUCTION 2 0.0002
414 LARYNGEAL OEDEMA 1 0.0002
415 SCOLIOSIS 1 0.0002
416 INFUSION SITE EXTRAVASATION 1 0.0002
417 DRY EYE 8 0.0002
418 PRE-EXISTING CONDITION IMPROVED 1 0.0002
419 PNEUMONIA ASPIRATION 4 0.0002
420 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
421 NASAL DRYNESS 1 0.0002
422 INFUSION SITE SWELLING 1 0.0002
423 PHOTOPSIA 1 0.0002
424 BLOOD URINE PRESENT 3 0.0002
425 MUSCLE ATROPHY 2 0.0002
426 BLOOD PRESSURE INCREASED 24 0.0002
427 PULMONARY OEDEMA 7 0.0002
428 PNEUMONIA 50 0.0002
429 EAR PAIN 3 0.0002
430 ANGINA UNSTABLE 1 0.0002
431 HAEMORRHOIDS 3 0.0002
432 TENDON DISORDER 1 0.0002
433 TOOTH INFECTION 2 0.0002
434 PULMONARY CONGESTION 2 0.0002
435 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
436 UPPER LIMB FRACTURE 3 0.0002
437 FUNGAL INFECTION 5 0.0001
438 GAIT INABILITY 5 0.0001
439 QUALITY OF LIFE DECREASED 2 0.0001
440 BRONCHIECTASIS 1 0.0001
441 POSTOPERATIVE WOUND INFECTION 1 0.0001
442 SINUS CONGESTION 2 0.0001
443 PRODUCT TASTE ABNORMAL 2 0.0001
444 PRODUCT LABEL ISSUE 1 0.0001
445 OSTEOPOROSIS 6 0.0001
446 ECCHYMOSIS 1 0.0001
447 RIB FRACTURE 3 0.0001
448 CORONARY ARTERY OCCLUSION 2 0.0001
449 RESPIRATORY DISTRESS 4 0.0001
450 LYMPHOEDEMA 1 0.0001
451 PULMONARY HYPERTENSION 3 0.0001
452 LARGE INTESTINE PERFORATION 1 0.0001
453 ORAL DISCOMFORT 2 0.0001
454 HYPERTRANSAMINASAEMIA 1 0.0001
455 FORMICATION 1 0.0001
456 NECK PAIN 8 0.0001
457 DEMENTIA 4 0.0001
458 CARPAL TUNNEL SYNDROME 2 0.0001
459 DEFAECATION URGENCY 1 0.0001
460 RIGHT VENTRICULAR FAILURE 1 0.0001
461 DIVERTICULUM 1 0.0001
462 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
463 HYPERSOMNIA 4 0.0001
464 ANOSMIA 2 0.0001
465 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
466 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
467 MAJOR DEPRESSION 1 0.0001
468 BLINDNESS TRANSIENT 1 0.0001
469 HYPOPHOSPHATAEMIA 1 0.0001
470 SKIN HAEMORRHAGE 2 0.0001
471 HYDRONEPHROSIS 1 0.0001
472 HEART RATE IRREGULAR 3 0.0001
473 HALLUCINATION 10 0.0001
474 HYPOAESTHESIA ORAL 2 0.0001
475 PAROSMIA 1 0.0001
476 CHRONIC KIDNEY DISEASE 10 0.0001
477 THYROID DISORDER 2 0.0001
478 LYMPHOMA 2 0.0001
479 CONCUSSION 1 0.0001
480 OEDEMA 7 0.0001
481 HYPOALBUMINAEMIA 1 0.0001
482 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
483 PULMONARY HAEMORRHAGE 1 0.0001
484 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
485 NASAL DISCOMFORT 1 0.0001
486 RENAL CYST 1 0.0001
487 HALLUCINATION, AUDITORY 2 0.0001
488 GINGIVAL PAIN 1 0.0001
489 COVID-19 22 0.0001
490 LOSS OF CONSCIOUSNESS 16 0.0001
491 RHINITIS 1 0.0001
492 FRUSTRATION TOLERANCE DECREASED 1 0.0001
493 DRY MOUTH 10 0.0001
494 SWELLING FACE 8 0.0001
495 DECUBITUS ULCER 1 0.0001
496 EYE DISORDER 4 0.0001
497 PHOTOSENSITIVITY REACTION 2 0.0001
498 SPINAL COMPRESSION FRACTURE 1 0.0001
499 EXPIRED PRODUCT ADMINISTERED 4 0.0001
500 VIRAL INFECTION 4 0.0001
501 POLLAKIURIA 5 0.0001
502 DYSPNOEA 67 0.0001
503 HYPOPHAGIA 3 0.0001
504 RECTAL HAEMORRHAGE 5 0.0001
505 SKIN HYPERPIGMENTATION 1 0.0001
506 BLOOD MAGNESIUM DECREASED 1 0.0001
507 RASH GENERALISED 3 0.0001
508 CARDIAC MURMUR 1 0.0001
509 PLEURAL EFFUSION 7 0.0001
510 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
511 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
512 ANHEDONIA 3 0.0001
513 GROIN PAIN 1 0.0001
514 SPINAL OSTEOARTHRITIS 1 0.0001
515 COLD SWEAT 2 0.0001
516 LUNG INFILTRATION 1 0.0001
517 HEAD DISCOMFORT 2 0.0001
518 EAR INFECTION 3 0.0001
519 FACIAL PAIN 1 0.0001
520 HEART RATE INCREASED 11 0.0001
521 GASTROENTERITIS VIRAL 2 0.0001
522 PELVIC PAIN 2 0.0001
523 RESTLESS LEGS SYNDROME 2 0.0001
524 PANIC ATTACK 4 0.0001
525 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
526 EXOSTOSIS 1 0.0001
527 SKIN LESION 3 0.0001
528 NEPHROLITHIASIS 5 0.0001
529 RESPIRATORY ARREST 3 0.0001
530 HYPERHIDROSIS 14 0.0001
531 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
532 PRODUCT DISTRIBUTION ISSUE 1 0.0001
533 PERSONALITY CHANGE 1 0.0001
534 HEPATIC ENCEPHALOPATHY 1 0.0001
535 FLANK PAIN 1 0.0001
536 HEPATIC CIRRHOSIS 2 0.0001
537 TARDIVE DYSKINESIA 3 0.0001
538 PHOTOPHOBIA 2 0.0001
539 ASTHMA 12 0.0001
540 PAIN IN JAW 3 0.0001
541 SPINAL DISORDER 1 0.0001
542 DEPRESSION 24 0.0001
543 MUSCULOSKELETAL DISORDER 2 0.0001
544 RED BLOOD CELL COUNT DECREASED 3 0.0001
545 SLEEP APNOEA SYNDROME 2 0.0001
546 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
547 BLOOD GLUCOSE DECREASED 5 0.0001
548 BALANCE DISORDER 9 0.0001
549 LOWER LIMB FRACTURE 2 0.0001
550 ACUTE RESPIRATORY FAILURE 2 0.0001
551 DYSSTASIA 3 0.0001
552 TREMOR 17 0.0001
553 LUNG DISORDER 5 0.0001
554 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
555 BODY TEMPERATURE DECREASED 1 0.0001
556 HOSPICE CARE 1 0.0001
557 DISABILITY 2 0.0001
558 SINUS DISORDER 2 0.0001
559 BLADDER DISORDER 1 0.0001
560 BLOOD PRESSURE ABNORMAL 2 0.0001
561 HYPOTONIA 1 0.0001
562 APHASIA 3 0.0001
563 LACRIMATION INCREASED 3 0.0001
564 CELLULITIS 5 0.0001
565 FALL 33 0.0001
566 EMPHYSEMA 1 0.0001
567 TASTE DISORDER 2 0.0001
568 SUBARACHNOID HAEMORRHAGE 1 0.0001
569 SLUGGISHNESS 1 0.0001
570 EUPHORIC MOOD 1 0.0001
571 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
572 PRODUCT PREPARATION ERROR 2 0.0001
573 POOR VENOUS ACCESS 1 0.0001
574 SWOLLEN TONGUE 3 0.0001
575 FEELING ABNORMAL 23 0.0001
576 TENDERNESS 1 0.0001
577 NERVOUSNESS 5 0.0001
578 PRODUCT ODOUR ABNORMAL 1 0.0001
579 SPEECH DISORDER 5 0.0001
580 SCRATCH 1 0.0001
581 HEAD INJURY 3 0.0001
582 MEMORY IMPAIRMENT 13 0.0001
583 NEUROPATHY PERIPHERAL 9 0.0001
584 DIARRHOEA 61 0.0001
585 OSTEOARTHRITIS 4 0.0001
586 CYSTITIS 3 0.0001
587 MOOD SWINGS 3 0.0001
588 EATING DISORDER 2 0.0001
589 HIP FRACTURE 3 0.0001
590 LIVER FUNCTION TEST INCREASED 2 0.0001
591 DECREASED ACTIVITY 1 0.0001
592 PRURITUS GENERALISED 2 0.0001
593 PHARYNGITIS STREPTOCOCCAL 1 0.0001
594 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
595 FAECES DISCOLOURED 2 0.0001
596 PULMONARY THROMBOSIS 1 0.0001
597 HYPERSENSITIVITY 17 0.0001
598 OESOPHAGITIS 1 0.0001
599 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
600 STAPHYLOCOCCAL INFECTION 3 0.0001
601 INJECTION SITE NODULE 1 0.0001
602 LIP SWELLING 3 0.0001
603 SKIN DISORDER 3 0.0001
604 GLOSSODYNIA 2 0.0001
605 ORAL PAIN 2 0.0001
606 ANGER 3 0.0001
607 FLATULENCE 5 0.0001
608 IMPAIRED DRIVING ABILITY 1 0.0001
609 ASTHENIA 33 0.0001
610 DERMATITIS CONTACT 1 0.0001
611 SCAB 1 0.0001
612 CHOLECYSTECTOMY 1 0.0001
613 CARDIAC FAILURE CONGESTIVE 7 0.0001
614 NEOPLASM 1 0.0001
615 LETHARGY 5 0.0001
616 NIGHTMARE 3 0.0001
617 CONFUSIONAL STATE 14 0.0001
618 METASTASES TO LUNG 1 0.0001
619 PERICARDIAL EFFUSION 2 0.0001
620 EYELID OEDEMA 1 0.0001
621 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
622 HEART RATE DECREASED 3 0.0001
623 SPLENOMEGALY 1 0.0001
624 INJURY 6 0.0001
625 COVID-19 PNEUMONIA 1 0.0001
626 CATARACT 5 0.0001
627 HYPERLIPIDAEMIA 1 0.0001
628 MOBILITY DECREASED 6 0.0001
629 RENAL FAILURE 11 0.0001
630 LOCALISED INFECTION 2 0.0001
631 CRYING 3 0.0001
632 DEHYDRATION 11 0.0001
633 STOMATITIS 5 0.0001
634 WEIGHT DECREASED 23 0.0001
635 NOCTURIA 1 0.0001
636 ATRIAL FIBRILLATION 8 0.0001
637 URINARY TRACT INFECTION 14 0.0001
638 VERTIGO 5 0.0001
639 MUSCLE SPASMS 15 0.0001
640 DYSPEPSIA 8 0.0001
641 CARDIOMEGALY 1 0.0001
642 SPINAL OPERATION 1 0.0001
643 HYPERCALCAEMIA 1 0.0001
644 CYST 1 0.0001
645 ILEUS 1 0.0001
646 DIZZINESS 40 0.0001
647 SECRETION DISCHARGE 1 0.0001
648 UNEVALUABLE EVENT 6 0.0001
649 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
650 PRODUCT COMPLAINT 2 0.0001
651 HAEMATEMESIS 2 0.0001
652 FLUID RETENTION 4 0.0001
653 INJECTION SITE IRRITATION 1 0.0001
654 GAIT DISTURBANCE 15 0.0001
655 INTRAOCULAR PRESSURE INCREASED 1 0.0001
656 CHEST DISCOMFORT 8 0.0001
657 PAIN IN EXTREMITY 23 0.0001
658 PYREXIA 27 0.0001
659 MYDRIASIS 1 0.0001
660 URTICARIA 13 0.0001
661 ANAPHYLACTIC SHOCK 2 0.0001
662 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
663 ANXIETY 22 0.0001
664 HIATUS HERNIA 1 0.0001
665 HAEMATOMA 2 0.0001
666 INJECTION SITE INDURATION 1 0.0001
667 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
668 DIPLOPIA 2 0.0001
669 AMNESIA 5 0.0001
670 PLATELET COUNT INCREASED 1 0.0001
671 NODULE 1 0.0001
672 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
673 JOINT STIFFNESS 2 0.0001
674 BEDRIDDEN 1 0.0001
675 GASTRITIS 2 0.0001
676 ORAL CANDIDIASIS 1 0.0001
677 ABNORMAL BEHAVIOUR 3 0.0001
678 DISORIENTATION 3 0.0001
679 OROPHARYNGEAL PAIN 7 0.0001
680 CHEST PAIN 14 0.0001
681 HYPERTENSION 16 0.0001
682 EYE HAEMORRHAGE 1 0.0001
683 CARDIAC DISORDER 7 0.0001
684 JOINT RANGE OF MOTION DECREASED 1 0.0001
685 NAUSEA 59 0.0001
686 DYSKINESIA 3 0.0001
687 DYSPHAGIA 7 0.0001
688 PALLOR 2 0.0001
689 HEADACHE 46 0.0001
690 CONTUSION 7 0.0001
691 HAEMATOCHEZIA 4 0.0001
692 DIVERTICULITIS 2 0.0001
693 PROCEDURAL PAIN 2 0.0001
694 MENTAL STATUS CHANGES 2 0.0001
695 HYPOMAGNESAEMIA 1 0.0001
696 INFLUENZA 8 0.0001
697 APHONIA 1 0.0001
698 INSOMNIA 19 0.0001
699 OXYGEN SATURATION DECREASED 4 0.0001
700 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
701 RENAL FAILURE ACUTE 3 0.0001
702 SINUS TACHYCARDIA 1 0.0001
703 MUSCULAR WEAKNESS 8 0.0001
704 VOMITING 33 0.0001
705 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
706 SOMNOLENCE 14 0.0001
707 PARAESTHESIA ORAL 1 0.0001
708 MENTAL DISORDER 3 0.0001
709 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
710 CONSTIPATION 15 0.0001
711 FLUID OVERLOAD 1 0.0001
712 NEEDLE ISSUE 2 0.0001
713 PALPITATIONS 8 0.0001
714 BONE PAIN 4 0.0001
715 NASAL CONGESTION 4 0.0001
716 ASCITES 2 0.0001
717 PRODUCT DOSE OMISSION ISSUE 20 0.0001
718 PULMONARY MASS 1 0.0001
719 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
720 RESPIRATORY DISORDER 2 0.0001
721 BONE LOSS 1 0.0001
722 HOT FLUSH 5 0.0001
723 HEPATIC FAILURE 2 0.0001
724 CORONARY ARTERY DISEASE 2 0.0001
725 DEVICE FAILURE 1 0.0001
726 PLATELET COUNT DECREASED 7 0.0001
727 OEDEMA PERIPHERAL 8 0.0001
728 VISION BLURRED 9 0.0001
729 INSURANCE ISSUE 1 0.0001
730 TINNITUS 3 0.0001
731 INJECTION SITE SWELLING 5 0.0001
732 FEELING HOT 4 0.0001
733 DRUG ADMINISTRATION ERROR 2 0.0001
734 PHARYNGEAL OEDEMA 1 0.0001
735 EMOTIONAL DISORDER 2 0.0001
736 MUSCULOSKELETAL CHEST PAIN 1 0.0001
737 TENDONITIS 1 0.0001
738 COGNITIVE DISORDER 3 0.0001
739 SWELLING 6 0.0001
740 ARTHRITIS 5 0.0001
741 PNEUMOTHORAX 1 0.0001
742 OBESITY 1 0.0001
743 SCIATICA 1 0.0001
744 ABSCESS 1 0.0001
745 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
746 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
747 NIGHT SWEATS 2 0.0001
748 MUSCLE TIGHTNESS 1 0.0001
749 BLOOD POTASSIUM INCREASED 1 0.0001
750 DEEP VEIN THROMBOSIS 4 0.0001
751 CHOLELITHIASIS 2 0.0001
752 METASTASES TO BONE 1 0.0001
753 SEIZURE 7 0.0001
754 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
755 BLOOD PRESSURE DECREASED 4 0.0001
756 SYNCOPE 6 0.0001
757 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
758 CANDIDA INFECTION 1 0.0001
759 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
760 FATIGUE 46 0.0001
761 CEREBROVASCULAR ACCIDENT 10 0.0001
762 PRODUCT QUALITY ISSUE 8 0.0001
763 CIRCULATORY COLLAPSE 1 0.0001
764 HEPATIC ENZYME INCREASED 4 0.0001
765 HOSPITALISATION 9 0.0001
766 PERIPHERAL SWELLING 9 0.0001
767 SCAR 1 0.0001
768 ILLNESS 6 0.0001
769 JOINT SWELLING 7 0.0001
770 ABDOMINAL DISTENSION 6 0.0001
771 MUSCULOSKELETAL PAIN 3 0.0001
772 PARAESTHESIA 9 0.0001
773 RASH MACULAR 2 0.0001
774 BURNING SENSATION 4 0.0001
775 LYMPHADENOPATHY 2 0.0001
776 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
777 BACK PAIN 13 0.0001
778 GOUT 1 0.0001
779 DISTURBANCE IN ATTENTION 3 0.0001
780 PAIN 34 0.0001
781 OSTEOMYELITIS 1 0.0001
782 BONE DISORDER 1 0.0001
783 UNDERDOSE 4 0.0001
784 DEPENDENCE 3 0.0001
785 ACCIDENTAL OVERDOSE 2 0.0001
786 DYSURIA 2 0.0001
787 BLOOD GLUCOSE ABNORMAL 1 0.0001
788 CONJUNCTIVITIS 1 0.0001
789 AGRANULOCYTOSIS 1 0.0001
790 HEPATIC STEATOSIS 1 0.0001
791 MIDDLE INSOMNIA 1 0.0001
792 ABDOMINAL PAIN UPPER 11 0.0001
793 BLISTER 3 0.0001
794 INTESTINAL OBSTRUCTION 2 0.0001
795 BLOOD SODIUM DECREASED 1 0.0001
796 MYALGIA 9 0.0001
797 COLITIS 2 0.0001
798 FOOT FRACTURE 1 0.0001
799 GASTRIC ULCER 1 0.0001
800 FEELING JITTERY 1 0.0001
801 DIABETES MELLITUS 4 0.0001
802 MALAISE 23 0.0001
803 MIGRAINE 5 0.0001
804 ACUTE KIDNEY INJURY 8 0.0001
805 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
806 EYE IRRITATION 3 0.0001
807 SEROTONIN SYNDROME 1 0.0001
808 DYSTONIA 1 0.0001
809 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
810 PLASMA CELL MYELOMA 2 0.0001
811 CHILLS 6 0.0001
812 SURGERY 3 0.0001
813 KIDNEY INFECTION 1 0.0001
814 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
815 PRESCRIBED UNDERDOSE 1 0.0001
816 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
817 IRRITABILITY 3 0.0000
818 CARDIAC FAILURE 4 0.0000
819 THROMBOSIS 4 0.0000
820 PRODUCT PHYSICAL ISSUE 1 0.0000
821 PRODUCT ADMINISTRATION ERROR 1 0.0000
822 WEIGHT INCREASED 11 0.0000
823 BLINDNESS 2 0.0000
824 BODY TEMPERATURE INCREASED 1 0.0000
825 HAEMOGLOBIN DECREASED 5 0.0000
826 DRUG ABUSE 4 0.0000
827 ROAD TRAFFIC ACCIDENT 2 0.0000
828 DERMATITIS 1 0.0000
829 MOUTH ULCERATION 1 0.0000
830 DECREASED APPETITE 11 0.0000
831 IRRITABLE BOWEL SYNDROME 1 0.0000
832 POOR QUALITY SLEEP 1 0.0000
833 SKIN CANCER 1 0.0000
834 VAGINAL HAEMORRHAGE 2 0.0000
835 PRODUCT DISPENSING ERROR 1 0.0000
836 INTENTIONAL PRODUCT MISUSE 4 0.0000
837 INFUSION RELATED REACTION 3 0.0000
838 ANGIOEDEMA 2 0.0000
839 LIVER DISORDER 2 0.0000
840 NEOPLASM MALIGNANT 3 0.0000
841 DEVICE ISSUE 4 0.0000
842 SNEEZING 1 0.0000
843 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
844 RHEUMATOID ARTHRITIS 5 0.0000
845 INCORRECT DOSE ADMINISTERED 10 0.0000
846 ERYTHEMA 9 0.0000
847 SKIN IRRITATION 2 0.0000
848 RASH 19 0.0000
849 MUSCLE TWITCHING 1 0.0000
850 HYPOKALAEMIA 2 0.0000
851 ARTHRALGIA 18 0.0000
852 ABDOMINAL PAIN 10 0.0000
853 RENAL DISORDER 2 0.0000
854 BLOOD CHOLESTEROL INCREASED 2 0.0000
855 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
856 SLEEP DISORDER 3 0.0000
857 BLOOD GLUCOSE INCREASED 8 0.0000
858 DISEASE PROGRESSION 5 0.0000
859 ARRHYTHMIA 2 0.0000
860 OCULAR HYPERAEMIA 2 0.0000
861 PULMONARY EMBOLISM 4 0.0000
862 PRODUCT PRESCRIBING ERROR 1 0.0000
863 ANAEMIA 8 0.0000
864 HEPATIC CANCER 1 0.0000
865 INFECTION 6 0.0000
866 EMOTIONAL DISTRESS 5 0.0000
867 RESPIRATORY FAILURE 3 0.0000
868 PRESYNCOPE 1 0.0000
869 NEURALGIA 1 0.0000
870 AGITATION 3 0.0000
871 OSTEONECROSIS OF JAW 1 0.0000
872 DYSGEUSIA 3 0.0000
873 EXTRAPYRAMIDAL DISORDER 1 0.0000
874 HYPOAESTHESIA 6 0.0000
875 CONDITION AGGRAVATED 12 0.0000
876 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
877 SKIN ULCER 1 0.0000
878 EXPOSURE VIA SKIN CONTACT 1 0.0000
879 SEDATION 1 0.0000
880 DEPRESSED MOOD 2 0.0000
881 BRADYCARDIA 2 0.0000
882 FEAR 1 0.0000
883 JAUNDICE 1 0.0000
884 PAIN OF SKIN 1 0.0000
885 LIMB INJURY 1 0.0000
886 PNEUMONITIS 1 0.0000
887 MOOD ALTERED 1 0.0000
888 INFLUENZA LIKE ILLNESS 3 0.0000
889 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
890 DRUG INEFFECTIVE 48 0.0000
891 FEELING COLD 1 0.0000
892 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
893 CONVULSION 2 0.0000
894 ANGINA PECTORIS 1 0.0000
895 HYPOTENSION 7 0.0000
896 PANCREATIC CARCINOMA 1 0.0000
897 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
898 ACUTE MYOCARDIAL INFARCTION 1 0.0000
899 LABORATORY TEST ABNORMAL 1 0.0000
900 TACHYCARDIA 3 0.0000
901 OESOPHAGEAL CARCINOMA 1 0.0000
902 ADVERSE DRUG REACTION 3 0.0000
903 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
904 DISCOMFORT 2 0.0000
905 SUICIDAL IDEATION 3 0.0000
906 LIMB DISCOMFORT 1 0.0000
907 FEMUR FRACTURE 1 0.0000
908 VISUAL IMPAIRMENT 4 0.0000
909 EXPOSURE DURING PREGNANCY 2 0.0000
910 DRUG-INDUCED LIVER INJURY 1 0.0000
911 METABOLIC ACIDOSIS 1 0.0000
912 PRURITUS 12 0.0000
913 RHINORRHOEA 2 0.0000
914 PRODUCT DOSE OMISSION 2 0.0000
915 IMPAIRED HEALING 1 0.0000
916 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
917 OFF LABEL USE 26 0.0000
918 FLUSHING 3 0.0000
919 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
920 DELIRIUM 1 0.0000
921 NEOPLASM PROGRESSION 1 0.0000
922 HAEMORRHAGE 3 0.0000
923 MYOCARDIAL INFARCTION 5 0.0000
924 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
925 PRODUCT ADHESION ISSUE 1 0.0000
926 THERAPY INTERRUPTED 2 0.0000
927 DEATH 24 0.0000
928 OVERDOSE 6 0.0000
929 DRUG EFFECT INCOMPLETE 1 0.0000
930 HYPERGLYCAEMIA 1 0.0000
931 THROMBOCYTOPENIA 3 0.0000
932 HEPATIC FUNCTION ABNORMAL 1 0.0000
933 DYSARTHRIA 1 0.0000
934 DRUG DOSE OMISSION BY DEVICE 2 0.0000
935 INJECTION SITE BRUISING 2 0.0000
936 INJECTION SITE HAEMORRHAGE 2 0.0000
937 LUNG NEOPLASM MALIGNANT 1 0.0000
938 CARDIAC ARREST 2 0.0000
939 DRUG DOSE OMISSION 4 0.0000
940 RHABDOMYOLYSIS 1 0.0000
941 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
942 ABDOMINAL DISCOMFORT 4 0.0000
943 RENAL IMPAIRMENT 2 0.0000
944 TOXICITY TO VARIOUS AGENTS 4 0.0000
945 HYPOACUSIS 1 0.0000
946 DEVICE DISLOCATION 1 0.0000
947 MUSCULOSKELETAL STIFFNESS 2 0.0000
948 INJECTION SITE PAIN 7 0.0000
949 DRUG WITHDRAWAL SYNDROME 2 0.0000
950 DRY SKIN 3 0.0000
951 GASTROINTESTINAL DISORDER 2 0.0000
952 THERAPY NON-RESPONDER 1 0.0000
953 SKIN DISCOLOURATION 1 0.0000
954 COMA 1 0.0000
955 RASH ERYTHEMATOUS 1 0.0000
956 INTERSTITIAL LUNG DISEASE 1 0.0000
957 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
958 INFLAMMATION 1 0.0000
959 ECZEMA 1 0.0000
960 PANCREATITIS 1 0.0000
961 DRUG INTERACTION 3 0.0000
962 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
963 DRUG EFFECT DECREASED 1 0.0000
964 RASH PRURITIC 1 0.0000
965 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
966 ANAPHYLACTIC REACTION 1 0.0000
967 ARTHROPATHY 1 0.0000
968 MEDICATION ERROR 1 0.0000
969 SEPSIS 2 0.0000
970 EYE PAIN 1 0.0000
971 HERPES ZOSTER 1 0.0000
972 PRODUCT SUBSTITUTION ISSUE 1 0.0000
973 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
974 SUICIDE ATTEMPT 1 0.0000
975 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
976 INJECTION SITE ERYTHEMA 2 0.0000
977 PRODUCT USE ISSUE 3 0.0000
978 INTENTIONAL OVERDOSE 1 0.0000
979 BLOOD CREATININE INCREASED 1 0.0000
980 FEBRILE NEUTROPENIA 1 0.0000
981 INJECTION SITE PRURITUS 1 0.0000
982 NEUTROPENIA 2 0.0000
983 INJECTION SITE REACTION 1 0.0000
984 DEVICE MALFUNCTION 1 0.0000
985 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
986 SKIN BURNING SENSATION 1 0.0000
987 ADVERSE EVENT 1 0.0000
988 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
989 PSORIASIS 1 0.0000
990 DRUG DEPENDENCE 1 0.0000
991 NO ADVERSE EVENT 1 0.0000